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Abstract 
 
Problem statement: Chronic obstructive pulmonary disease (COPD) is characterized by not fully 
reversible progressing bronchial obstruction connected to abnormal inflammatory response to adverse 
particles or gases. The consequences are grave. 
Research Questions: Is there a connection between the perception of the quality of life and COPD 
determinants? 
Purpose of the Study: The purpose of this study was to determine the quality of life of patients 
with COPD in connection to the gravity of the disease, its length and treatment. 
Research methods: The data was acquired using standardized questionnaires: Medical Outcome 
Study Short Form-36 (SF-36) to assess the quality of life, Medical Research Council (MRC) – modified 
dyspnoea scale and the Nottingham screening questionnaire for malnutrition risk assessment. 120 
respondents partook in this research at the Clinic of Pulmonary Diseases and Tuberculosis – 61 men/59 
women with COPD aged 30–92 (64 on average). 
Findings: The respondents' physical and mental health was assessed in 8 dimensions. Patients with 
the 3rd–4th stage of COPD feel significantly limited in the physical health dimension. Patients diagnosed 
with COPD more than 6 years ago feel less vital than patients diagnosed one year ago. Undergoing rescue 
treatment has an impact on social activity. 
Conclusion: The quality of life rapidly worsens in the 3rd and 4th stages of COPD in the physical 
activity dimension, general health assessment, vitality and social activity. However, the results cannot be 
generalized and the study is in progress.  
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Keywords: Obstructive pulmonary disease, quality of life.  
 
 
 
http://dx.doi.org/10.15405/epsbs.2017.09.13 
Corresponding Author: Pavla Kudlová 
Selection and peer-review under responsibility of the Organizing Committee of the conference 
eISSN: 2357-1330 
	
	 135 
1. Introduction 
Chronic obstructive pulmonary disease (COPD) is one of the main causes in terms of global and 
also Czech morbidity and mortality. Approximately 500 to 600 million people are suffering from this 
disease, out of whom 2.74 million die of this disease each year. Around 8% of the total population in the 
Czech Republic are suffering from this disease (Zatloukal, 2007, p. 301; Kašák, 2013). COPD is a 
lifelong, progressing disease enormously worsening life quality of the patients, often leading to 
permanent disability and premature death. COPD also has severe psychosocial impact. People suffering 
from this disease may experience a change or even a loss of their role in the family, partnership, loss of 
job, social isolation, or lack of understanding (Skoupá, 2014, p. 12). It only affects adult population. It is 
one of the most frequent diseases of the lower respiratory tract in the Czech Republic. It lies in gradual 
and irreversible bronchial obstruction. It is usually accompanied by chronic inflammation affecting not 
only the respiratory tract but the whole organism. Both hereditary and environmental factors contribute to 
the occurrence of COPD (Neumannová, Kolek, 2012, p. 79; Kolek et al., 2014, p. 131). 
 
1.1. Chronic obstructive pulmonary disease 
COPD is a curable disease that can be prevented. Its pulmonary component is characterized by 
obstruction to the air flow in the bronchi (bronchial obstruction) that is not fully reversible. Bronchial 
obstruction progresses and is connected to an abnormal inflammatory response to adverse particles or 
gases. COPD has significant extrapulmonary effects that can contribute to its severity in individual 
patients (Neumannová, Kolek, 2012, p. 79). The classic trio of symptoms includes cough, production of 
sputum, and exertion dyspnoea. Advanced stages are characterized by gradually progressing dyspnoea, 
significant limitation of exertion tolerance, the onset of cyanosis and chronic respiratory insufficiency, 
and manifestations of right-hand side cardiac failure within chronic cor pulmonale. This disease is often 
associated with many comorbidities, such as cardiovascular disease, cachexia, osteoporosis, depressions, 
or diabetes. These associated diseases must be actively sought and adequately treated (GOLD 2017, p. 
24-26). 
1.1.1 Diagnostics of COPD 
The basic pillar of COPD diagnostics is a functional pulmonary examination focused on proving 
fixed bronchial obstruction that is not fully reversible on the administration of bronchodilatancia. Only 
patients in whom there is a suspicion that they have this disease based on their symptoms are examined. 
The key value is FEV1/FVC, the so-called Tiffeneau index. Post bronchial dilatation value of <0.70 is 
required in order to meet the diagnostic criteria (Kolek et al., 2014, p. 135-142). Chest x-ray is performed 
primarily in order to exclude complications – pneumonia, pneumothorax, or tumor. Arterial blood gases 
examination is indicated in patients with a rest SpO2<93% (Kolek et al., 2014, p. 135-142). 
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1.1.2 COPD Classification 
According to the traditional division GOLD, the scale of bronchial obstruction, i.e. the value of 
postbronchodilatational FEV1, is the primary lead to establishing the severity of the disease. COPD is 
divided based on the severity of bronchial obstruction established by means of spirometry into 4 stages (I 
– mild, II - moderate, III - severe, IV – extremely severe). In patients in clinical stages II, III, and IV we 
find a decreased postbronchodilatational value of forced expiratory volume (FEV1) below 80% of the 
expected relevant values (Table 01). 
 
Table 01. COPD stages according to GOLD 
Stage Symptoms Pulmonary functions 
0 – Imminent Chronic, sputum producing cough Normal  
I – Mild With or without chronic symptoms Mildly limited ventilation 
FEV1/FVC ˂ 70% 
FEV1 ≥ 80% 
II – Moderate Advanced symptomatology, dyspnoea 
resulting from physical load 
Worse ventilation 
FEV1/FVC ˂ 70% 
50% ≥ FEV1 ˂ 80% 
III – Severe Escalated dyspnoea and repeated 
exacerbations, strongly limiting the patient's 
quality of life 
Severe ventilation defect 
FEV1/FVC ˂ 70% 
30% ≥ FEV1˂ 50% 
IV – Extremely severe Severe chronic respiratory problems; the 
quality of life is even more limited; life 
threatening exacerbations 
Most severe ventilation 
defects 
FEV1/FVC < 70%  
FEV1 < 30%  
 
Inflammation and its subsequent pathological changes affect the respiratory tract, especially 
peripheral bronchi, pulmonary parenchyma and pulmonary arteries. 
Besides chronic pulmonary inflammation structural changes resulting from repeated damage and 
repair are also present. The hypothesis of accelerated aging of the lung as a possible cause of COPD is 
considered. The disease is further assessed based on subjective problems of the patient, the frequency of 
exacerbations, and the phenotype (the scale of obstruction is characterized in the same way, only using an 
Arabic number). There are groups A to D based on the problems and risks (risk is given by the number of 
exacerbations per year), and two subscales of subjective problems of the patient – COPD Assessment 
Test (CAT) and mMRC (Koblížek, Chlumský, 2016, p. 2-4). 
Phenotype classification is a bit simplifying as the phenotype does not necessarily be clearly 
expressed at the onset of the disease, or phenotypes may overlap. The key fact is that they can all develop 
to the stage of respiratory failure (GOLD 2017, p. 45). 
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1.1.3 COPD therapy 
The goal of the COPD therapy is to remove the symptoms, improve tolerance to physical load, to 
prevent disease progression, to improve life quality, prevention and treatment of complications, 
prevention and treatment of exacerbations, and decreasing mortality (GOLD 2017, p. 45). 
COPD therapy can be schemed into 4 basic steps – elimination of risks (giving up smoking 
immediately, anti-flu vaccination, etc.), causal treatment, phenotype treatment, chronic respiratory 
insufficiency treatment (GOLD 2017, p. 45). Less frequently mentioned but equally important is the 
treatment of all the present, especially cardiac comorbidities (cardiac failure, ischemic heart disease, atrial 
fibrillation, diabetes mellitus, etc.) (GOLD 2017, p. 45). 
Causal treatment includes both pharmacological (mostly inhalation medication + vaccination) and 
nonpharmacological treatment (physical activity, pulmonary rehabilitation, education and training of 
inhalation techniques). In the treatment of COPD the basic medication is made up, according to the stage 
of the disease and the patient's symptoms, of inhalation ß2agonist with a long term to ultra long term 
effect (LABA, U-LABA) and inhalation antagonist of muscarinic receptors, also with a long term to ultra 
long term effect (LAMA, U-LAMA). Treatment must be modified in such a way so that it best responds 
to the health condition of the patient (Kašák, 2014, p. 406-407). Bronchodilatational and anti-
inflammatory therapy is meant to improve the quality of life of the patient, decrease the frequency of 
COPD exacerbations, and limit the application of so-called rescue medication. In the treatment of COPD 
medication is gradually increased based on severity and the category of the disease (GOLD 2017). COPD 
with bronchiectases profits mainly from the administration of mucolytics, antibiotics, and physiotherapy. 
In patients with COPD who suffer from chronic respiratory insufficiency it is advisable to consider 
indications of so-called long term home oxygen therapy (Chlumský, 2016). 
Even surgical therapy may be used in the treatment of COPD (e.g. LVRS - Lung Volume 
Reduction Surgery, bullectomy or BVR - bronchoscopic volume reduction. During the treatment of 
COPD with respiratory failure it is necessary to consider indicating lung transplant. If counter-indicated, 
it is time for end-of-life care with an emphasis on diminishing dyspnoea and the accompanying 
symptoms, ideally via hospice care (Kolek et al., 2014, p. 148-150; Fanta, Votruba and Neuwirth, 2004, 
p. 44-45). 
 
1.2.  Assessment of quality of life in case of bronchial obstruction 
In COPD, the occurrence of which is strikingly higher than that of asthma, patients are relatively 
asymptomatic in early stages. They may not pay attention to chronic productive cough immediately from 
its onset. The main activities of daily life start to be limited only when FEV1 drops below 50% of its 
normal value. The fact that bronchial obstruction significantly affects the patient's life was verified using 
standardized questionnaires (Salajka, 2006, p. 60-61). 
In practice there are a number of questions that are focused at life quality. Questionnaires can be 
divided into generic (general), and specific (focused on the given disease) (Němec, 2009). Generic 
questionnaires can be used to assess the differences between individual groups, or to assess their long 
term development. These include, for example, the Sickness Impact Profile (SIP) - 136 questions, the 
Nottingham Health Profile (NHP) – 45 questions, the Medical Outcomes Study Short Form (SF-36) – 36 
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questions, Quality of Well Being (QWB) – 50 questions focused on well-being SF-36 – 36 questions 
according to Ware. 
The following questionnaires are considered as very good for assessing respiratory problems – the 
St. George Respiratory Questionnaire (SGRQ) – 76 questions, the Chronic Respiratory Disease 
Questionnaire (CRQ) – 20 questions, Breathing Problems Questionnaire (BPQ) – 33 questions and the 
Seattle Obstructive Lung Disease Questionnaire (SOLDQ) – 29 questions, etc. 
 
2. Problem Statement 
Quality of life can be divided based on objective and subjective standpoints. Subjective standpoint 
is more significant as it is the assessment made by the patient himself, as he perceives and feels his 
disease. Life quality is normally assessed using standardized life quality questionnaires. These map and 
assess the impact of the disease on the given individual, and the impact of the treatment itself on the 
patient's everyday life (Musil, Filip, 2011. p. 96-97). The main goal of this article was to determine life 
quality in patients with COPD in connection to the severity of the disease, its duration and treatment. 
 
3. Research Question 
Is there a connection between the perception of the quality of life and COPD determinants? 
 
4. Purpose of the Study 
Today's medicine can only inhibit the course of COPD, minimize the symptoms of the disease, 
prevent the onset of complications and COPD mortality, and/or delay them, and improve life quality of 
the patients (Kašák, 2006). 
 
4.1. Research goals 
 
The main goal of this article was to determine life quality in patients with COPD in connection to 
the severity of the disease, its duration and treatment. To this end, four partial goals were determined: 1) 
to find out whether it is women or men that suffer from COPD more frequently; 2) to find out whether it 
is patients with COPD stages III and IV or those with stages I and I that suffer from worse life quality; 3) 
to find a connection between the duration of the disease and life quality; 4) to find a connection between 
the application of rescue treatment and life quality. Four statistically verified zero hypotheses were set for 
the individual goals. 
 
4.2.   Pool of respondents and the organization of collecting data 
120 respondents partook in this research at the Clinic of Pulmonary Diseases and Tuberculosis of 
Olomouc University Hospital – 61 men/59 women with COPD aged 30–92 (64 on average). The 
youngest respondent was 30 years old and the oldest 92. The average age of the respondents who partook 
in this research was 64.25 years of age. Data was collected using questionnaire research between 
November 2016 and January 2017. Participation in this research was conditioned by the patients' 
undertaking a spirometry examination in the course of the last month in order to determine the stage of 
COPD according to the FEV1 value, which can only be measured spirometrically. 
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The permission to carry out this research was granted prior to the beginning of the research. 120 
properly filled out questionnaires were processed.  
 
5. Research Methods 
Three standardized questionnaires were used to collect the data: 1) the Medical Outcome Study 
Short From - 36 (SF-36); 2) the mMRC questionnaire; 3) the Nottingham Screening Questionnaire for the 
assessment of malnutrition risks. 
 
5.1. The SF-36 Questionnaire 
 
The SF-36 health survey is a 36-question abridged version that classifies life quality through age 
composition. This survey was published in 1992 by Ware and Sherbourne (Ware and Sherbourne, 1992; 
McHorney, Ware and Raczek, 1993). In its current form the SF-36 is a trademark of the Medical 
Outcomes Trust. The survey is divided into 8 subcategories and two main categories (physical and mental 
health). The 36-question survey includes an 8-dimension selection scale: A – Physical Functioning, B – 
Role-Physical, C –Bodily Pain, D – General Health (5 questions), E – Vitality (4 questions), F – Social 
Functioning (2 questions), G – Role Emotional (3 questions), H – Mental Health (5 questions). One 
question does not fall into any area/dimension. This question is focused on the current health condition 
compared to that one year ago  (Kalantar-Zadeh et al., 2003; Musil- Filip, 2011; Kalantar-Zadeh et al., 
2003; SF-36v2 Health Survey, © 2017). 
Own assessment of the survey is realized as a scoring algorithm calculated for each dimension 
individually. These dimensions take up the values of 0 – 100, where the lowest value means a generally 
worse value of the given dimension, thus lowering overall life quality, and vice versa. The resulting 
values are calculated as the arithmetical mean of the individual answers. For easier interpretation, the 
individual dimensions of this survey were further divided into two scales specially assessing overall 
physical health (PCS-Physical Component Summary) and mental health (MCS - Mental Component 
Summary). The higher the score the better total physical/mental health (Kalantar-Zadeh et al., 2003; Ware 
J. E., 2004; SF-36v2 Health Survey, © 2017). 
 
5.2. The mMRC scale 
 
The mMRC (Medical Research Council) scale is a modified dyspnoea scale that assesses degrees 
of dyspnoea using 5 questions. It is a semi-quantitative assessment of dyspnoea symptoms for persons 
with COPD. Answers are given zero (no dyspnoea) to four points (I feel dyspnoea at minimum exertion) 
(Evans et al., 2009; Topinková, 2005). 
 
5.3. The Nottingham Screening Questionnaire 
The Nottingham screening questionnaire is the most frequently used system evaluating the state of 
nutrition while focused on the BMI, unwanted weight loss in the past three months, reduction of food 
intake in the past 3 months, reduction of food intake in the past one month, and the stress factor, which 
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illustrates the patient's basic diseases (Nováková, 2012, s. 102 podle Sobotka, Basics in Clinical 
Nutrition, 2000). 
 
6. Findings 
Among the respondents that took part in the research there were 30 (25.00%) nonsmokers, 41 
(34.20%) smokers, 4 (3.30%) passive smokers, and 45 (37.50%) former smokers. 
Only 4 of them had their BMI below 18 (3.33%), 26 had their BMI 18-20 (21.66%), and the 
majority of respondents – 90 (75.00%) had their BMI value higher than 20. 
The most respondents were in the COPD stages 2 (52) and 3 (41) – for more see Figure 01. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 01. Division of respondents with COPD based on the stage of the disease 
 
 
Figure 01. Number of respondents with COPD and stages of the disease 
 
While asked what kind of treatment they were using for COPD, most respondents answered that 
they were taking long-term treatment to battle COPD together with rescue treatment – 63 (52.40%) 
respondents, 28 (23.40%) respondents were only taking rescue treatment. 
 
6.1. Assessment of mMRC 
The results have shown (Figure 02) that the respondents felt severe dyspnoea on most days in the 
past month. Most respondents 37 (30.83%) assessed their dyspnoea with grade 2, which means for 
dyspnoea they walk on an even terrain more slowly than their peers, or they even need to pause due to 
dyspnoea. A total of 26 (21.66%) respondents assessed their dyspnoea as number 4, which means that 
they were grasping for breath while getting dressed or undressed. A total of 23 (19.16%) respondents 
graded their dyspnoea as a three, which means that they must stop after having walked 100 meters or after 
a few minutes' walk on an even surface. A total of 21 (17.50%) respondents gave their dyspnoea a one, 
which means that they are grasping for breath while hurrying on an even surface or slightly uphill. The 
smallest number of respondents – 13 (10.83%) – gave their dyspnoea a zero, meaning that they only grasp 
for breath during physical exertion. 
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Figure 02. Number of respondents and the resulting score of the mMRC 
 
6.2. Assessment of the Nottingham Screening Questionnaire 
The score of 5 and more points suggests life threatening malnutrition. A total of 24 respondents 
achieved this score. The score of 3 to 4 points signals the risk of malnutrition. A total of 15 students 
achieved this score. Scoring 0-2 points (the standard) the respondent does not need a nutritional therapist 
or special support. A total of 81 respondents achieved the normal number of points – see Table 02. 
 
Table 02. Assessment of the Nottingham Screening Questionnaire for the assessment of malnutrition 
risks 
Score (total number of points) Number % out of the total number 
1 point 69 57.50% 
2 points 12 10.00% 
3 points   6   5.00% 
4 points   9   7.50% 
5 points 12 10.00 % 
6 points   8   6.66 % 
7 points   4   3.33 % 
 
6.3. Assessment of SF-36 
Statistically significant differences between patients undergoing and not undergoing rescue 
treatment were found in all the dimensions except for the perception of pain. In all the items where a 
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statistically significant difference was proven, the patients undergoing rescue treatment achieved a lower 
score of life quality assessment. We managed to prove that undergoing rescue treatment has an 
influence on life quality – see Table 03. 
 
Table 03. The influence of rescue treatment on life quality based on the u SF-36 
 8 dimensions of the SF-36 Rescue treatment Yes No 
Physical activity 
Mean 37.94 64.17 
Median 35.00 72.50 
p-value <0,001 
Physical activity is limited 
Mean 25.83 56.67 
Median 0.00 62.50 
p-value <0.001 
Limitation due to emotional problems 
Mean 48.52 75.56 
Median 33.33 100.00 
p-value 0.004 
Vitality 
Mean 32.33 49.50 
Median 35.00 42.50 
p-value 0.001 
Mental area 
Mean 49.87 61.33 
Median 48.00 56.00 
p-value 0.024 
Social activity 
Mean 47.08 60,00 
Median 50.00 50.00 
p-value 0.042 
Pain 
Mean 64.75 71.08 
Median 51.25 88.75 
p-value 0,486 
General assessment of health 
Mean 30.00 41.83 
Median 30.00 40.00 
p-value 0.006 
 
Then using Mann-Whitney U test we did not manage to prove that men and women differ in 
their assessment of general health. 
Using the Chi Quadrate Test we managed to prove that the stage of the disease has an 
influence on the feeling of a limitation resulting from physical health. According to the Cramér 
coefficient (=.471) dependency is moderate. According to the configuration table we can say that patients 
with stage III or IV of the disease felt much more limited due to their physical health. A shattering 
majority of patients with stage III or IV of the disease (76.92%) assessed their limitation using the lowest 
value – one. Statistically significantly more patients with stage I or II of the disease (33.82%) assessed 
their limitations resulting from physical health with the highest possible value – three. 
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Using the Kruskal-Wallis test we managed to prove that patients with an increasing period of 
time since their diagnosis was made felt increasingly tired. Statistically significant differences between 
patients with different length of time since their diagnosis was made were found in all dimensions. We 
can say that the longer the patient has been diagnosed with COPD, the worse he assesses life quality – see 
Table 04. 
 
Table 04. Time since a diagnosis was made and its influence on life quality (SF-36) 
 8 dimensions of the 
SF-36 
Time since making 
the diagnosis 
Within 1 year 1 - 5 years 6 - 10 years 
More than 11 
years 
Physical activity 
Mean 86.82 59.70 43.61 21.13 
Median 90.00 60.00 37.50 15.00 
p-value <0.001 
Limitation of 
physical activity 
Mean 77.27 51.52 31.25 8.75 
Median 75.00 50.00 25.00 0.00 
p-value <0.001 
Limitation due to 
emotional problems 
Mean 81.82 67.68 60.19 33.33 
Median 100.00 100.00 83.33 0.00 
p-value 0.0012 
Vitality 
Mean 65.00 43.94 35.00 24.25 
Median 75.00 40.00 30.00 25.00 
p-value <0.001 
Mental area 
Mean 75.27 57.70 51.56 43.50 
Median 72.00 52.00 52.00 44.00 
p-value <0.001 
Social activity 
Mean 68.18 62.12 54.51 31.88 
Median 62.50 62.50 56.25 31.25 
p-value <0.001 
Pain 
Mean 90.91 71.52 61.67 59.50 
Median 100.00 77.50 51.25 45.00 
p-value 0.022 
General assessment 
of health 
Mean 57.27 39.70 34.58 19.25 
Median 60.00 40.00 35.00 17.50 
p-value <0.001 
   
7. Conclusion 
In the selected group of respondents (gender, duration of disease, COPD stage, last value of FEV1 
from the last spirometry in %, way of treatment, BMI), physical and mental health were assessed in 8 
dimensions. We managed to prove that patients with a severe or extremely severe stage (III or IV) of 
COPD felt statistically significantly limited in the physical health dimension. In the vitality dimension, 
patients with COPD diagnosed for more than 6 years felt less vital than those diagnosed with it one year 
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ago. Undergoing rescue treatment has an influence on life quality. That is why early diagnostics and 
adequate treatment are important in these patients. The most important are giving up smoking 
permanently, regular monitoring of the patient, and ceaseless education including the family. 
Multidisciplinary approach of all fields of expertise caring for the patient and his comorbidities is 
inevitable. With the patient's active approach and using the full potential of health care a full-fledged life 
of the patient can be ensured. 
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